Skip to main content

Table 1 The usage of vancomycin in the pre-intervention and intervention periods

From: Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence

 

Pre-intervention period

Intervention period

P value

Total amount of vancomycin prescribed (DDDs/1000 patient-days)

37.6

32.1

< 0.001

Amount of empirical vancomycin (DDDs/1000 patient-days)

23.9

19.9

0.005

Amount of inappropriate continued empirical vancomycin (DDDs/1000 patient-days)

8.0

5.8

0.009

  1. Abbreviations: DDD defined daily dose